Friday, June 26, 2020

Vitamin D may be key to reducing side effect of new cancer drugs

Image credit FDA Healthnews.com

CANCER DIGEST – June 26, 2020 – New research indicates that taking vitamin D supplements may help prevent one of the potentially serious side effects of a revolutionary form of anti-cancer therapy, called checkpoint inhibitors, a new study shows. 

The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS).

Friday, June 19, 2020

Movers have lower risk of dying of cancer

Image credit – MD Anderson
CANCER DIGEST – June 19, 2020 – A new study shows that the most sedentary individuals had an 82 percent higher risk of dying of cancer compared to the least sedentary individuals.

Led by Susan Gilchrist M.D., associate professor of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center the study involved a group of participants in the REGARDS study,

Friday, June 12, 2020

Aspirin taken daily for two years still lowers cancer risk 10 years later

Image credit – Newcastle University
CANCER DIGEST – June 12, 2020 – Two aspirin a day for two years reduced the risk of inherited bowel cancer 10 years after stopping the aspirin treatment, an analysis of research data has revealed.

The findings come from results of the international trial called CaPP2, which involved 861 patients with Lynch syndrome from around the world. Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common cause of hereditary colorectal (colon) cancer. The study appears in the June 12, 2020 The Lancet.

Friday, June 5, 2020

Genetic variant identified for higher rates of African American prostate cancer

CANCER DIGEST – June 5, 2020 – A study of prostate cancer in Americans of African descent has found a genetic variant that appears to increase the risk of prostate cancer in black men. The study appears in the May 11, 2020 journal European Urology.

Armed with this new information, clinicians may be able to screen for prostate cancer earlier and treat it sooner, according to study author Christopher Haiman, ScD.